Vaccininum-Injeel D 20, D 30, D 200 0.367 ml each.
Vaccininum-Injeel forte D 8, D 20, D 30, D 200 0.275 ml each.
Sequelae, e.g. too excessive reactions after vaccination against smallpox, advantageously in association with Silicea-Injeel, Sulfur-Injeel S, Hepar sulfuris-Injeel, Mercurius solubilis Hahnemanni lnjeel and Thuja-Injeel S. In addition, for headaches, exogenic depression, conjunctivitis, blepharitis, iritis, purulent rhinitis as well as for polyarthritis rheumatica and rheumatic paresis, postvaccinal nephritis with albuminuria and haematuria; further, for hypermenorrhoea, varicella and quite particularly for herpes zoster and herpes simplex (as mixed injection with Variolinum-lnjeel); however, also for erysipelas, phlegmons and acute eczema; likewise for precordial pains, cardiac erethism, thoracic paracentesis, loss of appetite and revulsion at the sight and smell of food (Julian). In general for serious toxic levels and for septic diseases (in association with Traumeel S, Baptisia-Injeel S, Lachesis-Injeel S, Echinacea-Injeel forte, Pyrogenium-Injeel). Experimentally for aphthae (with Engystol N, possibly also Myrtillus-Injeel, Beta vulgaris rubra-Injeel, Mucosa comp, etc.).
| created with Help to RTF file format converter |